Cian Healthcare (BOM:542678) Debt-to-Revenue : 0.96 (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cian Healthcare Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Cian Healthcare's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹282.0 Mil. Cian Healthcare's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹275.0 Mil. Cian Healthcare's annualized Revenue for the quarter that ended in Mar. 2024 was ₹581.7 Mil. Cian Healthcare's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.96.

Cian Healthcare Debt-to-Revenue Historical Data

The historical data trend for Cian Healthcare's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cian Healthcare Debt-to-Revenue Chart

Cian Healthcare Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Revenue

Get a 7-Day Free Trial

1.28

0.96

0.81

0.89

0.90

Cian Healthcare Semi-Annual Data
	Mar16	Mar17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Debt-to-Revenue	Get a 7-Day Free Trial										1.02	0.83	0.99	0.89	0.96

Competitive Comparison of Cian Healthcare's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Cian Healthcare's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cian Healthcare's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cian Healthcare's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cian Healthcare's Debt-to-Revenue falls into.

Cian Healthcare Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Cian Healthcare's Debt-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(281.951	+	274.962)	/	616.955
	=	0.90

Cian Healthcare's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(281.951	+	274.962)	/	581.664
	=	0.96

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Mar. 2024) Revenue data.

Cian Healthcare Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cian Healthcare's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cian Healthcare (BOM:542678) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cian Healthcare Ltd (BOM:542678) » Definitions » Debt-to-Revenue

Traded in Other Exchanges

N/A

Address

Vitthal Rao Shivarkar Road, Office No. 508-511, 5th Floor, Sacred World, Above Macdonald, Wanowrie, Pune, MH, IND, 411040

Website

https://www.cian.co

Cian Healthcare Ltd is a fully integrated pharmaceutical company. It is engaged in the research, development, and manufacturing of different forms of tablets, capsules, soft gels, liquid orals, ointments/ creams & sachets. The company's portfolio comprises of gynecology, hematinic, cardio-diabetic, orthopedic, pediatric, derma-cosmetic, antibiotics, CNS, vitamins, and nutrient products. It operates in five sectors namely Export, Government Supplies, Merchant Export, Own Brand Franchise Business, and Third Party. The majority of the revenue is generated from the Indian Market.

Cian Healthcare (BOM:542678) Headlines

No Headlines